"Everyone is a Candidate for Some Positive Lifestyle Change," Guideline Author Suggests
Richard Rosenfeld, MD, MPH, MBA, led the development of lifestyle medicine guidelines to treat or even reverse prediabetes and type 2 diabetes.
Population-Wide Study Finds No Link Between Aluminum Exposure in Vaccines and Childhood Disorders
The Danish study analyzed a nationwide cohort of 2.1 million children and found no association between aluminum exposure and allergic, autoimmune, or neurodevelopmental conditions.
Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose
Your daily dose of the clinical news you may have missed.
ENDO 2025: Most Patients With Classic Congenital Adrenal Hyperplasia Experience High Glucocorticoid Exposure or Suboptimal Control
A new analysis of the CAHtalog phase 3 study showed approximately 95% of participants experienced either high glucocorticoid exposure or elevated androstenedione levels during treatment.
The Role of Stress Reduction in Cardiometabolic Disease Management for Patients with Obesity
Monu Khanna, MD, discusses the benefits of behavioral strategies, including yoga, breathwork, and dancing, in reducing cardiovascular disease risk in patients with obesity.
Turn Therapeutics Launches First Clinical Trial to Assess Topical IL-36 Inhibitor for Atopic Dermatitis
GX-03 has proven effective in preclinical trials, reducing disease severity by more than 50% vs placebo. Data from the current study are expected by year end.
Maternal Depression Impairs Parental Emotional Responsiveness, Daily Care for Infants, Children: Global Systematic Review
Maternal depression significantly disrupts parenting behaviors, impacting child development and emotional bonding, according to an updated international literature review.
Lifestyle Medicine Guidelines for T2D, Prediabetes Are the Result of Remarkable Collaboration Across Specialties
Lead author for the American College of Lifestyle Medicine's new clinical practice guideline discusses the broad endorsement for the recommendations across participating groups.
Monu Khanna, MD: Essential Lifestyle Changes for Managing Obesity and Cardiometabolic Risk Factors
Obesity-Related Cancer Deaths More Than Tripled in the US from 1999 to 2020
ENDO 2025. Older adults, rural populations, and residents in the Midwest experienced the highest mortality rates, according to new data.
FDA to Review GSK's Application for Expanded Use of RSV Vaccine in High-Risk Adults Aged 18 to 49
GSK's RSV vaccine Arexvy would join shots from Pfizer and Moderna for the younger adult population, broadening choice for those with risk factors for severe disease.
FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data
FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.
AstraZeneca's Aldosterone Inhibitor Baxdrostat Effective Against Resistant HTN in Late-Stage Trial
Baxdrostat met the primary and all secondary endpoints, setting up a first regulatory filing for the selective aldosterone synthase inhibitor, according to AstraZeneca.
Treatment Options for Obesity-Related Cardiometabolic Diseases: Clinician Insights for Primary Care
Treatment should address root causes, including lifestyle modifications, stress management, and gut health, Monu Khanna, MD, told Patient Care.
HHS Secretary RFK, Jr, Cancels July 10 USPSTF Meeting, Prompting Fear Across Primary Care Professional Groups
The abrupt cancellation, without warning or cause, has medical groups and health care leaders concerned about patient access to no-cost preventive services.
Machine Learning Predicts Subjective Cognitive Decline During Menopause: Novel Framework for Early Detection
Key predictors of the severity of self-reported cognitive complaints among nurses going through menopause included symptom severity and climacteric stage.
Elinzanetant Gets UK Nod for Moderate to Severe Vasomotor Symptoms in Menopause: Is the US Far Behind?
Bayer's elinzanetant gains UK approval as the first dual-action, nonhormonal treatment for menopausal symptoms.
It Takes a Multispecialty Team to Support and Sustain Patient-Centered Lifestyle Behavior Change
Lifestyle medicine integrates a spectrum of therapeutic lifestyle interventions best delivered by specialists who are often available to create a "virtual" team.
9 Drugs Approved for Primary Care: Q2 2025
Review 9 new FDA-approved drugs that may soon find a place in your prescribing routine, including new treatments for migraine, CSU, RSV, and more.
Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD
Verekitug is the only biologic in development for COPD that targets the TSLP receptor directly.
